Decentralized science infrastructure

Structured ownership in scientific intellectual property.

Arcstone gives qualified participants access to research-backed intellectual property through transparent legal structures, milestone-based funding and tokenized ownership records.

Review opportunities Read the investment model

$18.4mResearch financed

37Active programs

12Research partners

9Licensing events

Investment model

Three steps. Clear rights. Documented progress.

Each opportunity is supported by a defined legal framework, an intellectual property schedule, a funding plan and an independent scientific review.

Acquire participation rights

Investors receive a tokenized record linked to contractual rights in a specified research asset, patent application, dataset or licensing vehicle.

Monitor milestone delivery

Funds are released against published milestones. Reports, expenditure and external reviews remain available in the project data room.

Participate in outcomes

Depending on the structure, holders may receive governance rights, licensing distributions, transfer rights or approved early-access benefits.

Open research

Programs currently accepting commitments.

All entries below are demonstration content and should be replaced with verified laboratories, legal entities, budgets and scientific documentation before launch.

Program	Field	Stage	Target	Committed
Selective Senescent Cell Clearance ARC-IP-0048	Longevity	Preclinical	$2.0m	71%
Precision Gene Repair Platform ARC-IP-0051	Genomics	In vitro	$3.4m	48%
Synaptic Restoration Initiative ARC-IP-0055	Neuroscience	Discovery	$1.6m	83%
Regenerative Liver Matrix ARC-IP-0062	Regenerative medicine	Protocol review	$4.8m	29%

Project data room

Scientific evidence should be reviewed, not marketed.

PDF 01 Independent scientific review Open

PDF 02 IP ownership and licensing schedule Open

PDF 03 Milestone and capital release plan Open

DATA Research update archive Open

Scientific board

Independent review before capital allocation.

Replace these placeholder profiles with real experts, verified affiliations, publications, conflict disclosures and links to institutional pages.

Photo: National Cancer Institute / Unsplash

Dr. Elena Maren, PhD

Molecular biology and translational research

Publications

Laboratory researcher using a microscope

Photo: Sina Bahar / Unsplash

Prof. Adrian Cole, MD

Clinical development and trial strategy

Publications

Photo: Julia Koblitz / Unsplash

Dr. Maya Linden, PhD

Genomics and intellectual property review

Publications

Scientist conducting laboratory research

Photo: National Cancer Institute / Unsplash

Dr. Marcus Vale, PhD

Neuroscience and research ethics

Publications

Investor access

Review the legal structure before connecting capital.

Access to tokenized research opportunities may be restricted by jurisdiction, investor status and project-specific eligibility requirements.